|
2024
|
Invention
|
Methods and compositions for improving in vivo survival of midbrain dopamine neurons.
The presen... |
|
|
Invention
|
Cdc7 kinase inhibitors and uses thereof.
The invention provides compounds, methods, pharmaceutic... |
|
|
Invention
|
Selective androgen receptor modulator based radiopharmaceuticals for imaging androgen receptor. T... |
|
|
Invention
|
Inhibition of pcbp2 to enhance efficacy of immunotherapy. The present disclosure provides methods... |
|
|
Invention
|
Immune checkpoint blockade to prevent malignancy in individuals at high-risk for hereditary misma... |
|
|
Invention
|
Determining quantitative measures of tumors from biomedical images. The present disclosure is dir... |
|
|
Invention
|
Tp53 hotspot mutations and uses thereof. Provided and featured are novel recombinant T cell recep... |
|
|
Invention
|
Age-modulating compounds and methods for making age-modulated cells. Provided are age-modulated c... |
|
|
Invention
|
Anti-hpv antibodies and uses thereof.
The presently disclosed subject matter provides antibodies... |
|
|
Invention
|
Galectin-3-targeted and p-selectin-targeted nanotherapies. The present technology relates general... |
|
|
Invention
|
Cells expressing fas ligand and cflip polypeptides and uses thereof.
The presently disclosed sub... |
|
|
Invention
|
Cells expressing fas ligand polypeptides and fas knockout and uses thereof.
The presently disclo... |
|
|
Invention
|
Anti-pd-l1 immunoglobulin-related compositions comprising il-15-il-15ra fusion polypeptides and u... |
|
|
Invention
|
Proteomic biomarkers for predicting cancer-associated venous thromboembolism. The present disclos... |
|
|
Invention
|
Methods for treating cancer patients with homologous recombination deficiency based on pathognomo... |
|
|
Invention
|
Methods for pre-operative lung ablation prediction using deep learning. The present disclosure re... |
|
|
Invention
|
Methods for targeting protein structures using information theory. The present disclosure provide... |
|
|
Invention
|
Organoid co-cultures and methods of use thereof.
The present disclosure provides organoid co-cul... |
|
|
Invention
|
Compositions and methods for inducing viral mimicry in cancer cells. The present disclosure provi... |
|
|
Invention
|
Models for determining retrotransposon (rt) insertion burden and implications in cancer therapy. ... |
|
|
Invention
|
Sarcoma cancer vaccines and uses thereof. The present disclosure provides vaccine compositions co... |
|
|
Invention
|
Anti-cancer treatments and methods of use thereof. This invention is directed to anti-cancer trea... |
|
|
Invention
|
Nanoparticle-based theranostic platform for diagnosis and treatment of senescence-related patholo... |
|
|
Invention
|
Methods for treating gastrointestinal inflammatory diseases using alpha-ketoglutarate (akg) modul... |
|
|
Invention
|
Enhanced fusion polypeptide for immunotherapy. The presently disclosed subject matter provides me... |
|
|
Invention
|
Methods for treating fet rearranged cancers with atr inhibitors or chk1 inhibitors. The present d... |
|
|
Invention
|
Dlk1 -targeting antibodies and uses thereof. e.ge.g., antibodies or antigen binding fragments the... |
|
|
Invention
|
Combining induction of ferroptosis with targeted agents for cancer therapy. The present invention... |
|
|
Invention
|
Cytotoxic epoxyketone compounds, precursors, compositions, and methods of use. The present disclo... |
|
|
Invention
|
Il-10 receptor antibodies and methods of use thereof. The invention is directed to human monoclon... |
|
|
Invention
|
Methods for tagging molecules. The present invention is directed to a method for tagging molecule... |
|
|
Invention
|
Microenvironment actuated t-cells and uses thereof. Disclosed herein are engineered T cells compr... |
|
|
Invention
|
Cells and compositions for treating cancer. The presently disclosed subject matter provides compo... |
|
|
Invention
|
Engineered immune cells expressing anti-u5 snrnp200 antibodies and uses thereof. Provided herein ... |
|
|
Invention
|
Antibodies targeting cd3 and uses thereof. The presently disclosed subject matter provides antibo... |
|
|
Invention
|
Immune cell compositions comprising gp4 modifications and uses thereof. Provided herein are compo... |
|
|
Invention
|
Anti-dll3 antibodies and uses thereof.
The presently disclosed subject matter provides antibodie... |
|
|
Invention
|
Methods and compositions for promoting survival & proliferation of endothelial cells & stimulatin... |
|
2023
|
Invention
|
Improved methods for producing cells. The presently disclosed subject matter provides methods for... |
|
|
Invention
|
Antibodies and antigen binding fragments thereof binding to chimeric receptors and uses thereof. ... |
|
2022
|
Invention
|
Vessels, devices, processes, and systems for tracking and managing items with circuitous custody ... |
|
|
Invention
|
Systems and methods for magnetic resonance fingerprinting with increased volumetric coverage usin... |
|
|
Invention
|
Epigenetic targets in clonal hematopoiesis.
The present disclosure provides, in some embodiments... |
|
|
Invention
|
Anti-tshr multi-specific antibodies and uses thereof.
The present technology provides anti-Thyro... |
|
|
Invention
|
Systems and methods for anonymization of image data.
Described embodiments provide systems and m... |
|
|
Invention
|
Methods and compositions for the treatment of alzheimer’s disease.
The present technology relate... |
|
|
Invention
|
Detection of somatic mutational signatures from whole genome sequencing of cell-free dna.
The pr... |
|
|
Invention
|
Combination therapy with dexamethasone and tumor-specific t cell engaging multi-specific antibodi... |
|
|
Invention
|
Cd38 chimeric co-stimulating receptor and uses thereof.
The presently disclosed subject matter p... |
|
|
Invention
|
Tracking apobec mutational signatures in tumor cells.
The present disclosure provides methods fo... |
